1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow ILT-101: new trials by email Literature Review of ILT-101 trials Research Report on ILT-101
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ILT-101 in Patients With Active Moderate to Severe Systemic Lupus Erythematosus (SLE) ILT-101, Placebo - Systemic Lupus Erythematosus | Phase 2 | Completed | Iltoo Pharma | 100 | 2017-01-18 | 2019-03-05 |
Lupus Erythematosus, Systemic (1)
Iltoo Pharma (1)
Austria (1) · Bulgaria (1) · France (1) · Germany (1) · Italy (1) · Mauritius (1) · Mexico (1) · Portugal (1) · Romania (1) · Spain (1)
2016 (1)